[{"type": "title", "data": "OB Postpartum VTE Thromboprophylaxis"}, {"type": "category", "data": "Admit/Transfer/Discharge"}, {"type": "note", "data": "Refer to Society of Obstetricians and Gynaecologists of Canada (SOGC) Clinical Practice Guideline Venous Thromboembolism and Antithrombotic Therapy in Pregnancy "}, {"type": "category", "data": "Patient Care"}, {"type": "order", "data": "Patient Education", "value": ""}, {"type": "sentence", "data": "Women at moderate or high risk should be advised of the signs and symptoms of venous thromboembolism"}, {"type": "order", "data": "Patient Education", "value": ""}, {"type": "sentence", "data": "Educate patients for self administration of pharmacologic thromboprophylaxis, prevention of VTE and signs / symptoms of abnormal bleeding"}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "Review attached VTE decision tree to determine risk category for patient before completing orders "}, {"type": "note", "data": "VTE RISK IS LOW "}, {"type": "order", "data": "Ambulate", "value": ""}, {"type": "sentence", "data": "T;N, Mobilize early and avoid dehydration"}, {"type": "note", "data": "VTE RISK IS MODERATE OR HIGH WITHOUT CONTRAINDICATION TO ANTICOAGULANTS "}, {"type": "note", "data": "<P>Pharmacologic Thromboprophylaxis CONTRAINDICATED if:</P><P>- Active bleeding of clinical significance requiring intervention </P><P>- High risk of serious bleeding or bleeding into a critical site (e.g. intracranial, intraspinal, pericardial, intraocular, retroperitoneal, intra-articular) </P><P>- Known major bleeding disorder or acquired coagulopathy (consider Hematology consult) </P><P>- Platelet count LESS than 50 X 10^9/L (consider Hematology consult) </P><P>- If history of Heparin-Induced Thrombocytopenia (HIT), DO NOT give LMWH or heparin. Consult Hematology / Internal Medicine for alternate anticoagulation </P><P>- Patient already receiving therapeutic anticoagulation </P><P>- Hypersensitivity to low molecular weight heparin (LMWH) [enoxaparin]</P>"}, {"type": "note", "data": "<P>Pharmacologic Thromboprophylaxis should be HELD UNTIL FURTHER ASSESSMENT in clinical setting if </P><P>- Blood patch is planned or being considered, do not give LMWH (enoxaparin) </P><P>- PPH with active bleeding and medically unstable: delay LMWH until stable </P><P>- If intra-op &quot;oozing&quot;, ordering physician may delay the initial dose </P>"}, {"type": "note", "data": "DO NOT administer low molecular weight heparin (LMWH) (enoxaparin) within 4 hours of epidural catheter removal "}, {"type": "note", "data": "Hold low molecular weight heparin (enoxaparin) prophylaxis for 12 hours prior to removal of epidural catheter "}, {"type": "note", "data": "Placeholder for VTE Prophylaxis Contraindication"}, {"type": "order", "data": "Communication Order", "value": ""}, {"type": "sentence", "data": "VTE Prophylaxis Contraindication: Active Bleeding Requiring Intervention"}, {"type": "sentence", "data": "VTE Prophylaxis Contraindication: Risk of Serious Bleed in Critical Site"}, {"type": "sentence", "data": "VTE Prophylaxis Contraindication: Known Major Bleed Disorder/Coagulopathy"}, {"type": "sentence", "data": "VTE Prophylaxis Contraindication: Platelet Count Less Than 50 x 10^9/L"}, {"type": "sentence", "data": "VTE Prophylaxis Contraindication: History of Heparin-Induced Thrombocytopenia, DO NOT give LMWH or heparin"}, {"type": "sentence", "data": "VTE Prophylaxis Contraindication: Receiving Therapeutic Anticoagulant"}, {"type": "note", "data": "Pharmacologic Prophylaxis: "}, {"type": "note", "data": "BID dosing is contraindicated if epidural left in situ, consult anesthesia "}, {"type": "note", "data": "If patient has abnormal renal function consult pharmacy or internal medicine prior to next dose of enoxaparin "}, {"type": "order", "data": "enoxaparin", "value": ""}, {"type": "sentence", "data": "40 mg, SubQ, Injection, q24hr(sched)"}, {"type": "sentence", "data": "40 mg, SubQ, Injection, q12hr(sched)"}, {"type": "sentence", "data": "60 mg, SubQ, Injection, q12hr(sched)"}, {"type": "note", "data": "VTE RISK IS MODERATE WITH CONTRAINDICATION TO ANTICOAGULANTS or HIGH RISK "}, {"type": "note", "data": "Mechanical Prophylaxis (SCD) CONTRAINDICATED if: - Acute stroke with immobility (unable to walk independently to the toilet) - Peripheral vascular disease with absent pedal pulses - Severe peripheral neuropathy - Skin breakdown, ulcers, gangrene, cellulitis or dermatitis - Skin grafting within last 3 months - Allergy to stocking or compression cuff materials - Unable to size or apply properly due to deformity, recent surgery or trauma "}, {"type": "order", "data": "Communication Order", "value": ""}, {"type": "sentence", "data": "No mechanical prophylaxis because of contraindications"}, {"type": "order", "data": "Sequential Compression Device (SCD) Application", "value": ""}, {"type": "sentence", "data": "T;N, Constant Order, Full Leg; apply by 1 hour post-delivery to lower limb(s) continuously or until patient is fully ambulatory.  Interrupt for skin care, assessments, ambulation only"}, {"type": "order", "data": "Sequential Compression Device (SCD) Application", "value": ""}, {"type": "sentence", "data": "T;N, Constant Order, Below knee; apply by 1 hour post-delivery to lower limb(s) continuously or until patient is fully ambulatory.  Interrupt for skin care, assessments, ambulation only"}, {"type": "category", "data": "Communication Orders"}, {"type": "order", "data": "Conditional Order", "value": ""}, {"type": "sentence", "data": "If/when planned blood patch, active bleeding or medically unstable PPH, then HOLD LMWH (enoxaparin)"}, {"type": "order", "data": "Conditional Order", "value": ""}, {"type": "sentence", "data": "If/when protamine sulfate needed for reversal, then contact Provider STAT for order (Refer to Parenteral Drug Administration Manual for protamine dosing)"}]
